Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-MSN Antibody (R3H02)

Catalog #:   RHD69504 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG1
Applications: ELISA, FCM, IHC, WB
Accession: P26038
Overview

Catalog No.

RHD69504

Species reactivity

Human, Monkey

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Tested applications

ELISA: 1:10000, FCM: 1:200-1:400, IHC: 1:200-1:1000, WB: 1:500-1:2000

Target

Membrane-organizing extension spike protein, MSN, Moesin

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P26038

Applications

ELISA, FCM, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% Sodium Azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R3H02

Data Image
  • Flow Cytometry
    Flow cytometric analysis of Jurkat cells using MSN mouse mAb (green) and negative control (red).
  • Immunohistochemical
    Immunohistochemical analysis of paraffin-embedded human colon tissues using MSN mouse mAb with DAB staining.
  • Western blot
    Western blot analysis using MSN mouse mAb against HeLa (1), A431 (2),Jurkat(3), HEK293(4), and COS7 (5) cell lysate.
References

Next-gen novel nanocage-based multivalent vaccine candidate to tackle the rising menace of Mpox., PMID:40480973

Biological and Clinical Relevance of Genetic Alterations in Peripheral T-cell Lymphomas., PMID:40416001

Rational selection of the monoclonal α-synuclein antibody amlenetug (Lu AF82422) for the treatment of α-synucleinopathies., PMID:40404755

[Successful subcutaneous desensitization in a patient with systemic reaction due to ixekizumab]., PMID:40253637

TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors., PMID:40168999

A lipoprotein complex conjugated mesoporous silica as potent antibiotic adjuvant for synergistic antibacterial therapy of MRSA., PMID:40048969

Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experience., PMID:40027306

Enhanced mucosal immune response through nanoparticle delivery system based on chitosan-catechol and a recombinant antigen targeted towards M cells., PMID:40010449

Clinicopathological analysis of enlarged abdominal aortic aneurysms after endovascular aneurysm repair and the relationship with occult IgG4-related vascular disease., PMID:39937263

Aggregation-Induced Electrochemiluminescence of Silica-Confined Tetraphenylethylene with Pd Nanocube-Loaded Co3O4 Nanosheets as a Coreaction Accelerator for Sensitive Bioanalysis., PMID:39688358

Envenoming by a captive inland taipan, Oxyuranus microlepidotus (McCoy, 1879), Elapidae. A case report, observations on clinical efficacy of expired antivenom and review of O. microlepidotus envenoming., PMID:39674408

The impact of HER2-low status on pathological complete response and disease-free survival in early-stage breast cancer., PMID:39448928

Rapid identification of primary atopic disorders (PAD) by a clinical landmark-guided, upfront use of genomic sequencing., PMID:39381601

Hypersensitivity vs. uncommonly severe local envenoming by the red-back spider, Latrodectus hasselti Thorell, 1870 (Araneae: Theridiidae)., PMID:39182727

The influence of autoantibody profile, disease manifestations and demographic features on survival in systemic lupus erythematosus: a comparative study., PMID:39180533

Toxicity profile of camrelizumab-based immunotherapy in older adults with advanced cancer., PMID:39152261

Systematic Preparation of a 66-IgG Library with Symmetric and Asymmetric Homogeneous Glycans and Their Functional Evaluation., PMID:39106493

Local envenoming by the eastern Montpellier snake, Malpolon insignitus fuscus (Fleischmann, 1831), Psammophiidae, and review of the evidence-based medical risks of bites by Malpolon spp., PMID:38992508

Real-world outcomes of combined lenvatinib and anti-PD-1 in advanced melanoma: the Lenvamel study, a multicenter retrospective study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée)., PMID:38956747

Bioengineered self-assembled nanofibrils for high-affinity SARS-CoV-2 capture and neutralization., PMID:38955007

Novel Mutation in the Moesin (MSN) Gene Leads to Immunodeficiency with Epstein-Barr Virus (EBV) Infection and Dermatomyositis-Like Symptoms., PMID:38922539

Induction of antigen-specific immunity by mesoporous silica nanoparticles incorporating antigen peptides., PMID:38890051

Tixagevimab/Cilgavimab does not prevent COVID-19 in patients with multiple sclerosis and related disorders on B-cell depleting therapies., PMID:38795595

Combined transcriptome and proteome analysis reveals MSN and ARFIP2 as biomarkers for trastuzumab resistance of breast cancer., PMID:38750271

Illness Perceptions as a Predictor of Symptom Cluster Trajectories in Patients With Inflammatory Bowel Disease: A Latent Growth Mixture Model., PMID:38567854

Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas., PMID:38561019

Identifying Biomarkers and Therapeutic Targets by Multiomic Analysis for HNSCC: Precision Medicine and Healthcare Management., PMID:38524437

Bevacizumab improved prognosis for advanced EGFR-mutant lung adenocarcinoma with brain metastasis receiving cerebral radiotherapy., PMID:38478262

Fatigue predicts quality of life after leucine-rich glioma-inactivated 1-antibody encephalitis., PMID:38303486

Identification of high-performing antibodies for Moesin for use in Western Blot, immunoprecipitation, and immunofluorescence., PMID:38106655

Two cases of pediatric primary immunodeficiency caused by a familial moesin(MSN)gene mutation., PMID:38052292

Leveraging mesoporous silica nanomaterial for optimal immunotherapeutics against cancer., PMID:39872169

A bispecific antibody NXT007 exerts a hemostatic activity in hemophilia A monkeys enough to keep a nonhemophilic state., PMID:37940048

Practical Clinical Guidelines for Natalizumab Treatment in Patients With Relapsing Multiple Sclerosis., PMID:37920108

Antibodies targeting a quaternary site on SARS-CoV-2 spike glycoprotein prevent viral receptor engagement by conformational locking., PMID:37776849

[Manganese-based nanoparticles for chemodynamic therapy of gastrointestinal cancer]., PMID:37712282

Paraneoplastic autoimmune Laminin-332 syndrome (PALS): Anti-Laminin-332 mucous membrane pemphigoid as a prototype., PMID:37673192

Formulation development and comparability studies with an aluminum-salt adjuvanted SARS-CoV-2 spike ferritin nanoparticle vaccine antigen produced from two different cell lines., PMID:37620203

A quantitative sonoelastography evaluation of ocular and periocular elasticity after intravitreal ranibizumab injection., PMID:37598105

Bio-Functional Mesoporous Silica Nanoparticles as Nano-Structured Carriers in Cancer Theranostic Review on Recent Advancements., PMID:37592775

Glaucoma-Associated CDR1 Peptide Promotes RGC Survival in Retinal Explants through Molecular Interaction with Acidic Leucine Rich Nuclear Phosphoprotein 32A (ANP32A)., PMID:37509196

Anthracyclines versus No Anthracyclines in the Neoadjuvant Strategy for HER2+ Breast Cancer: Real-World Evidence., PMID:37479867

PEG-grafted arsenic trioxide-loaded mesoporous silica nanoparticles endowed with pH-triggered delivery for liver cancer therapy., PMID:37357799

Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer., PMID:37353120

IL12/23 Blockade for Refractory Immune-Mediated Colitis: 2-Center Experience., PMID:37216614

Nanoparticle-Mediated CD47-SIRPα Blockade and Calreticulin Exposure for Improved Cancer Chemo-Immunotherapy., PMID:37133900

A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates., PMID:37069151

Self-powered molecular imprinted photoelectrochemical sensing platform of sialic acid employing WO3/Bi2S3 photoanode and CuInS2 photocathode., PMID:37058944

Aggregation-Induced Electrochemiluminescence Frame of Silica-Confined Tetraphenylethylene Derivative Matrixes for CD44 Detection via Peptide Recognition., PMID:37038771

HLA typing of patients who developed subacute thyroiditis and Graves' disease after SARS-CoV-2 vaccination: a case report., PMID:36879263

Datasheet

Document Download

Anti-MSN Antibody (R3H02).pdf

 

$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-MSN Antibody (R3H02) [RHD69504]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only